The annual incidence of both pancreatic and liver cancer is outlined below, which translates to a global opportunity of more than US$2 billion for pancreatic treatment and US$1.4 billion for liver cancer assuming a US$25,000 price per dose of OncoSilTM.
https://www.google.com/amp/s/finfeed.com/small-caps/biotech/oncosil-verge-ce-mark-approval/amp/
The annual incidence of both pancreatic and liver cancer is...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.4¢ | 1.3¢ | $15.02K | 1.101M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 10964682 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 615300 | 4 |
View Market Depth
| Last trade - 10.27am 27/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |